Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade.

Gong Y, Wang L, Yu H, Alpert N, Cohen MD, Prophete C, Horton L, Sisco M, Park SH, Lee HW, Zelikoff J, Chen LC, Hashim D, Suarez-Farinas M, Donovan MJ, Aaronson SA, Galsky M, Zhu J, Taioli E, Oh WK.

Mol Cancer Res. 2019 Aug;17(8):1605-1612. doi: 10.1158/1541-7786.MCR-19-0115. Epub 2019 Jun 20. Erratum in: Mol Cancer Res. 2019 Aug;17(8):1774.

PMID:
31221798
2.

Genetic identification of a war-evacuated child in search of his own identity for more than seventy years.

Puig P, Barceló A, Lahoz R, Niubó À, Jiménez J, Soler-López M, Donovan MJ, Navarro J, Camps J, Garcia-Caldés M, Etxeberria F, Miró R.

Forensic Sci Int. 2019 May;298:312-315. doi: 10.1016/j.forsciint.2019.03.014. Epub 2019 Mar 15.

PMID:
30925350
3.

Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy.

Signaevsky M, Prastawa M, Farrell K, Tabish N, Baldwin E, Han N, Iida MA, Koll J, Bryce C, Purohit D, Haroutunian V, McKee AC, Stein TD, White CL 3rd, Walker J, Richardson TE, Hanson R, Donovan MJ, Cordon-Cardo C, Zeineh J, Fernandez G, Crary JF.

Lab Invest. 2019 Jul;99(7):1019-1029. doi: 10.1038/s41374-019-0202-4. Epub 2019 Feb 15.

PMID:
30770886
4.

Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer.

Puig P, Erill N, Terricabras M, Subirana I, González-García J, Asensi-Puig A, Donovan MJ, Mengual L, Agulló-Ortuño MT, Olivan M, Alcaraz A, López-Martín JA, de Torres I, Rodríguez-Peralto JL, Rodríguez-Antolín A, Morote J, González-Rumayor V.

BMC Res Notes. 2019 Jan 30;12(1):68. doi: 10.1186/s13104-019-4100-z.

5.

The Barrow Innovation Center: A Novel Program in Neurosurgery Resident Education and Medical Device Innovation.

Bohl MA, Mooney MA, Sheehy J, Morgan CD, Donovan MJ, Little A, Nakaji P.

Cureus. 2018 Feb 2;10(2):e2142. doi: 10.7759/cureus.2142.

6.

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.

McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, Torkler P, Noerholm M, Skog J, Shore N, Andriole G, Thompson I, Carroll P.

Eur Urol. 2018 Dec;74(6):731-738. doi: 10.1016/j.eururo.2018.08.019. Epub 2018 Sep 17.

7.

Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses.

Franzmann EJ, Donovan MJ.

Expert Rev Mol Diagn. 2018 Oct;18(10):837-844. doi: 10.1080/14737159.2018.1523008. Epub 2018 Sep 26. Review.

PMID:
30221559
8.

Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL.

J Clin Invest. 2018 Nov 1;128(11):4970-4979. doi: 10.1172/JCI99261. Epub 2018 Sep 24.

9.

Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test.

Donovan MJ, Fernandez G, Scott R, Khan FM, Zeineh J, Koll G, Gladoun N, Charytonowicz E, Tewari A, Cordon-Cardo C.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):594-603. doi: 10.1038/s41391-018-0067-4. Epub 2018 Aug 7.

PMID:
30087426
10.

A monolithic microsphere-fiber probe for spatially resolved Raman spectroscopy: Application to head and neck squamous cell carcinomas.

Holler S, Haig B, Donovan MJ, Sobrero M, Miles BA.

Rev Sci Instrum. 2018 Mar;89(3):034301. doi: 10.1063/1.5011771.

PMID:
29604745
11.
12.

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.

Galsky MD, Wang H, Hahn NM, Twardowski P, Pal SK, Albany C, Fleming MT, Starodub A, Hauke RJ, Yu M, Zhao Q, Sonpavde G, Donovan MJ, Patel VG, Sfakianos JP, Domingo-Domenech J, Oh WK, Akers N, Losic B, Gnjatic S, Schadt EE, Chen R, Kim-Schulze S, Bhardwaj N, Uzilov AV.

Eur Urol. 2018 May;73(5):751-759. doi: 10.1016/j.eururo.2017.12.001. Epub 2017 Dec 13.

PMID:
29248319
13.

Editorial Comment.

Zeineh J, Donovan MJ.

Urology. 2017 Dec;110:90-91. doi: 10.1016/j.urology.2017.07.057. Epub 2017 Oct 16. No abstract available.

PMID:
29050642
14.

Raman Spectroscopy of Head and Neck Cancer: Separation of Malignant and Healthy Tissue Using Signatures Outside the "Fingerprint" Region.

Holler S, Mansley E, Mazzeo C, Donovan MJ, Sobrero M, Miles BA.

Biosensors (Basel). 2017 May 14;7(2). pii: E20. doi: 10.3390/bios7020020.

15.

Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.

Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB.

Cold Spring Harb Mol Case Stud. 2017 May;3(3):a001602. doi: 10.1101/mcs.a001602.

16.

Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.

Donovan MJ, Cordon-Cardo C.

Mol Diagn Ther. 2017 Apr;21(2):115-123. doi: 10.1007/s40291-016-0249-5. Review.

PMID:
28000172
17.

Development and clinical application of an integrative genomic approach to personalized cancer therapy.

Uzilov AV, Ding W, Fink MY, Antipin Y, Brohl AS, Davis C, Lau CY, Pandya C, Shah H, Kasai Y, Powell J, Micchelli M, Castellanos R, Zhang Z, Linderman M, Kinoshita Y, Zweig M, Raustad K, Cheung K, Castillo D, Wooten M, Bourzgui I, Newman LC, Deikus G, Mathew B, Zhu J, Glicksberg BS, Moe AS, Liao J, Edelmann L, Dudley JT, Maki RG, Kasarskis A, Holcombe RF, Mahajan M, Hao K, Reva B, Longtine J, Starcevic D, Sebra R, Donovan MJ, Li S, Schadt EE, Chen R.

Genome Med. 2016 Jun 1;8(1):62. doi: 10.1186/s13073-016-0313-0.

18.

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.

Motamedinia P, Scott AN, Bate KL, Sadeghi N, Salazar G, Shapiro E, Ahn J, Lipsky M, Lin J, Hruby GW, Badani KK, Petrylak DP, Benson MC, Donovan MJ, Comper WD, McKiernan JM, Russo LM.

PLoS One. 2016 May 4;11(5):e0154507. doi: 10.1371/journal.pone.0154507. eCollection 2016.

19.

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.

McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM Jr, Carroll P.

JAMA Oncol. 2016 Jul 1;2(7):882-9. doi: 10.1001/jamaoncol.2016.0097.

PMID:
27032035
20.

A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.

Donovan MJ, Noerholm M, Bentink S, Belzer S, Skog J, O'Neill V, Cochran JS, Brown GA.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):370-5. doi: 10.1038/pcan.2015.40. Epub 2015 Sep 8.

PMID:
26345389
22.

Programmable and multiparameter DNA-based logic platform for cancer recognition and targeted therapy.

You M, Zhu G, Chen T, Donovan MJ, Tan W.

J Am Chem Soc. 2015 Jan 21;137(2):667-74. doi: 10.1021/ja509263k. Epub 2014 Nov 25.

23.

Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.

Donovan MJ, Cordon-Cardo C.

Expert Rev Mol Diagn. 2014 Nov;14(8):1023-31. doi: 10.1586/14737159.2014.965151. Review.

PMID:
25327491
24.

Hospital reimbursement for carotid stenting and endarterectomy.

Donovan MJ, Ramirez DE, Crenshaw GD, Smith TA, Bazan HA, Sternbergh WC 3rd.

J Endovasc Ther. 2014 Apr;21(2):296-302. doi: 10.1583/13-4549.1.

PMID:
24754290
25.

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.

Donovan MJ, Cordon-Cardo C.

Curr Opin Urol. 2014 May;24(3):303-10. doi: 10.1097/MOU.0000000000000051. Review.

PMID:
24625431
26.

Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.

Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P.

Nat Neurosci. 2014 Jan;17(1):121-30. doi: 10.1038/nn.3588. Epub 2013 Nov 24.

27.

Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.

Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ, Heeger PS.

Am J Transplant. 2013 Oct;13(10):2530-9. doi: 10.1111/ajt.12405. Epub 2013 Sep 6.

28.

A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.

Zhao Z, Meng H, Wang N, Donovan MJ, Fu T, You M, Chen Z, Zhang X, Tan W.

Angew Chem Int Ed Engl. 2013 Jul 15;52(29):7487-91. doi: 10.1002/anie.201302557. Epub 2013 Jun 11.

PMID:
23757374
29.

Aptamers from cell-based selection for bioanalytical applications.

Tan W, Donovan MJ, Jiang J.

Chem Rev. 2013 Apr 10;113(4):2842-62. doi: 10.1021/cr300468w. Epub 2013 Mar 19. Review. No abstract available.

30.

Predicting high-risk disease using tissue biomarkers.

Donovan MJ, Cordon-Cardo C.

Curr Opin Urol. 2013 May;23(3):245-51. doi: 10.1097/MOU.0b013e32835f89cc. Review.

PMID:
23478499
31.

DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis.

Wang H, Donovan MJ, Meng L, Zhao Z, Kim Y, Ye M, Tan W.

Chemistry. 2013 Apr 2;19(14):4633-9. doi: 10.1002/chem.201204440. Epub 2013 Feb 20.

32.

Using aptamers for cancer biomarker discovery.

Chang YM, Donovan MJ, Tan W.

J Nucleic Acids. 2013;2013:817350. doi: 10.1155/2013/817350. Epub 2013 Jan 15.

33.

Double-strand DNA-templated formation of copper nanoparticles as fluorescent probe for label free nuclease enzyme detection.

Hu R, Liu YR, Kong RM, Donovan MJ, Zhang XB, Tan W, Shen GL, Yu RQ.

Biosens Bioelectron. 2013 Apr 15;42:31-5. doi: 10.1016/j.bios.2012.10.037. Epub 2012 Oct 29.

PMID:
23202326
34.

Nucleic acid aptamers: an emerging frontier in cancer therapy.

Zhu G, Ye M, Donovan MJ, Song E, Zhao Z, Tan W.

Chem Commun (Camb). 2012 Nov 4;48(85):10472-80. Review.

35.

Novel dry powder inhaler particle-dispersion systems.

Donovan MJ, Gibbons A, Herpin MJ, Marek S, McGill SL, Smyth HD.

Ther Deliv. 2011 Oct;2(10):1295-311. Review.

PMID:
22826884
36.

Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.

Donovan MJ, Tripathi V, Favila MA, Geraci NS, Lange MC, Ballhorn W, McDowell MA.

Parasite Immunol. 2012 Oct;34(10):464-72. doi: 10.1111/j.1365-3024.2012.01380.x.

37.

Dry powder inhaler device influence on carrier particle performance.

Donovan MJ, Kim SH, Raman V, Smyth HD.

J Pharm Sci. 2012 Mar;101(3):1097-107. doi: 10.1002/jps.22824. Epub 2011 Nov 17.

PMID:
22095397
38.

Personalized approach to prostate cancer prognosis.

Donovan MJ, Costa J, Cordon-Cardo C.

Arch Esp Urol. 2011 Oct;64(8):783-91. Review. English, Spanish.

PMID:
22052759
39.

Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points.

Graversen JA, Suh LK, Mues AC, Korets R, Donovan MJ, Khan FM, Liu Q, Landman J, Gupta M, McKiernan JM, Badani KK.

J Endourol. 2012 May;26(5):451-6. doi: 10.1089/end.2011.0192. Epub 2011 Sep 23.

PMID:
21942796
40.

Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery.

Donovan MJ, Khan FM, Powell D, Bayer-Zubek V, Cordon-Cardo C, Costa J, Eastham J, Scardino P.

BJU Int. 2012 Jan;109(1):40-5. doi: 10.1111/j.1464-410X.2011.10398.x. Epub 2011 Jul 19.

41.

Aptamer-drug conjugation for targeted tumor cell therapy.

Donovan MJ, Meng L, Chen T, Zhang Y, Sefah K, Tan W.

Methods Mol Biol. 2011;764:141-52. doi: 10.1007/978-1-61779-188-8_9.

PMID:
21748638
42.

A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer.

Donovan MJ, Khan FM, Bayer-Zubek V, Powell D, Costa J, Cordon-Cardo C.

BJU Int. 2012 Jan;109(2):207-13. doi: 10.1111/j.1464-410X.2011.10316.x. Epub 2011 Jul 6.

43.

Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.

Kim HS, Moreira DM, Jayachandran J, Gerber L, Bañez LL, Vollmer RT, Lark AL, Donovan MJ, Powell D, Khan FM, Freedland SJ.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):262-5. doi: 10.1038/pcan.2011.18. Epub 2011 Apr 26.

PMID:
21519348
44.

Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose.

Marek SR, Donovan MJ, Smyth HD.

Eur J Pharm Biopharm. 2011 May;78(1):97-106. doi: 10.1016/j.ejpb.2010.12.020. Epub 2010 Dec 21.

PMID:
21182942
45.

Personalized approach to prostate cancer prognosis.

Donovan MJ, Costa J, Cordon-Cardo C.

Minerva Urol Nefrol. 2010 Sep;62(3):231-9. Review.

PMID:
20940693
46.

Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.

Donovan MJ, Smyth HD.

Int J Pharm. 2010 Dec 15;402(1-2):1-9. doi: 10.1016/j.ijpharm.2010.08.045. Epub 2010 Sep 15.

PMID:
20816928
47.

Differential verbal, visual, and spatial working memory in written language production.

Raulerson BA 3rd, Donovan MJ, Whiteford AP, Kellogg RT.

Percept Mot Skills. 2010 Feb;110(1):229-44.

PMID:
20391888
48.

Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.

Donovan MJ, Osman I, Khan FM, Vengrenyuk Y, Capodieci P, Koscuiszka M, Anand A, Cordon-Cardo C, Costa J, Scher HI.

BJU Int. 2010 Feb;105(4):462-7. doi: 10.1111/j.1464-410X.2009.08747.x. Epub 2009 Jul 14.

49.

Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology.

Donovan MJ, Costa J, Cordon-Cardo C.

Cancer. 2009 Jul 1;115(13 Suppl):3078-84. doi: 10.1002/cncr.24353. Review.

50.

Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner.

Donovan MJ, Maciuba BZ, Mahan CE, McDowell MA.

Exp Parasitol. 2009 Sep;123(1):58-64. doi: 10.1016/j.exppara.2009.05.012. Epub 2009 Jun 3.

Supplemental Content

Loading ...
Support Center